Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|January 31, 2022
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinomaChwee Ming Lim, Anthony Liou, Michelle Poon, et al.
International Journal of Hematology|April 14, 2021
Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trialCharles Chuah, Liang Piu Koh, Tontanai Numbenjapon, et al.
Current Drug Metabolism|April 26, 2022
Elevated Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Predict Drug-Induced Acute Kidney InjuryK Akalya, Tanusya Murali Murali, Anantharaman Vathsala, et al.
British Journal of Haematology|July 31, 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosisAnimesh Pardanani, Ayalew Tefferi, Tamás Masszi, et al.
Leukemia & Lymphoma|January 28, 2012
Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemiaEunice S Wang, Karen Yee, Liang Piu Koh, et al.
Infection Control and Hospital Epidemiology|May 16, 2025
Reducing inappropriate antibiotic use in febrile neutropenia in hematology patients through the implementation of an antibiotic de-escalation protocolJinghao Nicholas Ngiam, Victor Ling, Matthew Chung Yi Koh, et al.
Orphanet Journal of Rare Diseases|December 6, 2014
Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsSiok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, et al.
Expert Review of Hematology|October 9, 2019
Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literatureJoanne Lee, Susan Swee-Shan Hue, Stephanie Q Ko, et al.
Annals of Hematology|December 19, 2014
WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patientsLiyuan Ma, Siguo Hao, Colin Diong, et al.
Leukemia & Lymphoma|August 21, 2014
Pre-transplant achievement of negativity in minimal residual disease and French-American-British L1 morphology predict superior outcome after allogeneic transplant for Philadelphia chromosome positive acute lymphoblastic leukemia: an analysis of Southeast Asian patientsLiyuan Ma, Siguo Hao, Colin Diong, et al.
Pageof 7